You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: December 4, 2023

Roche Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ROCHE, and what generic and branded alternatives to ROCHE drugs are available?

ROCHE has sixty-one approved drugs.

Summary for Roche

US Patents:	0
Tradenames:	49
Ingredients:	45
NDAs:	61
Patent Litigation for Roche:	See patent lawsuits for Roche

Drugs and US Patents for Roche

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roche Palo	FEMSTAT	butoconazole nitrate	SUPPOSITORY;VAGINAL	019359-001	Nov 25, 1985		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Roche	GANTRISIN	sulfisoxazole acetyl	SYRUP;ORAL	009182-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Roche	DEMADEX	torsemide	INJECTABLE;INJECTION	020137-002	Aug 23, 1993		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Roche Palo	TORADOL	ketorolac tromethamine	TABLET;ORAL	019645-001	Dec 20, 1991		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Roche	LORFAN	levallorphan tartrate	INJECTABLE;INJECTION	010423-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Roche	TAMIFLU	oseltamivir phosphate	CAPSULE;ORAL	021087-001	Oct 27, 1999	AB	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Roche

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Roche	KYTRIL	granisetron hydrochloride	INJECTABLE;INJECTION	020239-004	Mar 11, 1994	6,294,548	⤷ Try a Trial
Roche Palo	AEROBID	flunisolide	AEROSOL, METERED;INHALATION	018340-001	Aug 17, 1984	4,933,168	⤷ Try a Trial
Roche	DEMADEX	torsemide	INJECTABLE;INJECTION	020137-002	Aug 23, 1993	4,822,807	⤷ Try a Trial
Roche Palo	CYTOVENE	ganciclovir	CAPSULE;ORAL	020460-002	Dec 12, 1997	4,507,305	⤷ Try a Trial
Roche	MENRIUM 5-2	chlordiazepoxide; estrogens, esterified	TABLET;ORAL	014740-002	Approved Prior to Jan 1, 1982	4,316,897	⤷ Try a Trial
Roche Palo	TICLID	ticlopidine hydrochloride	TABLET;ORAL	019979-002	Oct 31, 1991	4,051,141	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ROCHE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	0.1 mg/mL, 1 mL single dose vial	➤ Subscribe	2007-03-08
➤ Subscribe	Injection	1 mg/mL, 4 mL multi-dose vials	➤ Subscribe	2004-07-19
➤ Subscribe	Tablets	2.5 mg and 150 mg	➤ Subscribe	2007-05-16
➤ Subscribe	Capsule	75 mg	➤ Subscribe	2010-11-15
➤ Subscribe	Oral Suspension	6 mg/mL	➤ Subscribe	2015-06-18
➤ Subscribe	Injection	1 mg/mL, 1 mL vials	➤ Subscribe	2004-06-01
➤ Subscribe	Injection	1 mg/mL, 3 mL Vial	➤ Subscribe	2007-08-31
➤ Subscribe	For Oral Suspension	200 mg/mL	➤ Subscribe	2011-03-25
➤ Subscribe	Capsules	30 mg and 45 mg	➤ Subscribe	2011-08-02

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Colorcon

McKinsey

Johnson and Johnson

Moodys

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.